Condition: Spinal Cord Injuries
Interventions: Behavioral: Community-based Exercise Intervention group (CBE); Behavioral: Exercise Education Control group (EEG)
Sponsors: Washington University School of Medicine; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting
ClinicalTrials.gov: Neurology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
Condition: Parkinson Disease
Intervention: Drug: Rivastigmine transdermal patch
Sponsors: University of Maryland; National Institute on Aging (NIA)
Recruiting
ClinicalTrials.gov: Neurology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
May 7, 2019ClinicalTrials.govComments OffNeurologyCholinergic | Cognition | Disease | Mobility | Neurotransmission | Parkinson
Conditions: Cognitive Impairment; Elderly
Interventions: Drug: 2g Centella asiatica water extract product; Drug: 4g Centella asiatica water extract product
Sponsors: Oregon Health and Science University; National Center for Complementary and Integrative Health (NCCIH)
Not yet recruiting
ClinicalTrials.gov: Neurology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
May 6, 2019ClinicalTrials.govComments OffNeurologyAsiatica | Centella | Cognitive | Impairment | Mild | Pharmacokinetics | Product
Conditions: Myasthenia Gravis; Guillain-Barre Syndrome; Multiple Sclerosis; Seizures; Parkinsonism; Meningitis; Encephalitis; Headache; Vestibular Disorder; Spondylosis; Normal Pressure Hydrocephalus
Interventions: Behavioral: Current standard discharge educational intervention; Behavioral: Personalized discharge educational intervention
Sponsor: Dartmouth-Hitchcock Medical Center
Recruiting
ClinicalTrials.gov: Neurology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
Conditions: Healthy; Elderly
Interventions: Drug: 2g Centella asiatica water extract product; Drug: 4g Centella asiatica water extract product
Sponsor: Oregon Health and Science University
Not yet recruiting
ClinicalTrials.gov: Neurology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
April 26, 2019ClinicalTrials.govComments OffNeurologyAsiatica | Centella | Elderly | Pharmacokinetics
Condition: Episodic Migraine
Interventions: Drug: Erenumab; Drug: Oral Prophylactic
Sponsors: Amgen; Novartis
Not yet recruiting
ClinicalTrials.gov: Neurology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
Condition: Alzheimer’s Disease
Interventions: Drug: RO7105705; Drug: Placebo; Drug: [18F]GTP1
Sponsor: Genentech, Inc.
Recruiting
ClinicalTrials.gov: Neurology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
April 24, 2019ClinicalTrials.govComments OffNeurologyAlzheimer's | Disease | Moderate | Patients | RO7105705 | Study
